Bridgewater Associates’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Buy
177,921
+174,543
+5,167% +$12.7M 0.06% 272
2026
Q1
$221K Sell
3,378
-9,932
-75% -$738K ﹤0.01% 977
2025
Q4
$1.05M Sell
13,310
-41,376
-76% -$3.17M ﹤0.01% 872
2025
Q3
$3.99M Buy
+54,686
New +$4.01M 0.02% 541
2025
Q2
Sell
-3,781
Closed -$288K 746
2025
Q1
$288K Sell
3,781
-5,501
-59% -$410K ﹤0.01% 614
2024
Q4
$613K Sell
9,282
-9,593
-51% -$672K ﹤0.01% 559
2024
Q3
$1.32M Buy
+18,875
New +$1.14M 0.01% 563

Other funds holding SOLV

Bridgewater Associates's SOLV Position: Q2 2026 in Review

Bridgewater Associates increased its Solventum (SOLV) stake by 5,167% in Q2 2026, buying an estimated $12.7M and bringing the position to 177,921 shares worth $13.7M. The position accounts for 0.06% of the portfolio, ranked #272.

Bridgewater Associates first reported a position in SOLV in Q3 2024 and has held it in 7 quarters since. 873 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Bridgewater Associates held 177,921 shares of Solventum worth $13.7M as of Q2 2026.
  • Bridgewater Associates bought 174,543 Solventum shares in Q2 2026, an estimated $12.7M.
  • Solventum made up 0.06% of Bridgewater Associates's portfolio in Q2 2026, its #272 holding.
  • Bridgewater Associates first reported a position in Solventum in Q3 2024 and has held it in 7 quarters since.
  • 873 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.